AI assistant
Lineage Cell Therapeutics Inc. — Director's Dealing 2012
Jul 31, 2012
6895_dirs_2012-07-31_93b30409-bb95-49c9-88b3-b867473a761c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-07-30
Reporting Person: KINGSLEY ALFRED D (Director, See Remarks, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-30 | Common Shares, no par value | J | 140000 | $4.7661 | Disposed | 7512394 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares, no par value | 1968505 | Indirect |
| Common Shares, no par value | 490373 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Puchase Common Shares | $4.60 | 2017-06-30 | Common Shares (50000) | 50000 | Direct |
| Option to Puchase Common Shares | $5.13 | 2016-06-30 | Common Shares (50000) | 50000 | Direct |
| Option to Puchase Common Shares | $5.45 | 2015-08-09 | Common Shares (50000) | 50000 | Direct |
| Option to Puchase Common Shares | $2.30 | 2014-07-01 | Common Shares (50000) | 50000 | Direct |
Footnotes
F1: On July 30, 2012, Mr. Kingsley transferred 140,000 BioTime common shares to BioTime's subsidiary LifeMap, Inc. in exchange for shares of LifeMap common stock under the terms of a Share Exchange and Contribution Agreement (the "LifeMap Agreement").
F2: Price determined under the LifeMap Agreement as the highest volume weighted average closing price per share on the NYSE MKT for ten consecutive trading days during the period from July 1, 2012 through July 31, 2012.
F3: Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
F4: 12,500 options will become exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013 based upon continued service on the board of directors.
F5: 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
F6: 12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
F7: 12,500 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.